Hookipa Pharma, Inc. Forecast, price target & analysts
$0.87
1.70%
today
Nasdaq,
Apr 04, 05:44 pm CET
Hookipa Pharma, Inc. Target price 2025 - Analyst rating & recommendation
Powered by
Hookipa Pharma, Inc. Classifications & Recommendation:
Buy
33%
Hold
67%
Hookipa Pharma, Inc. Price Target
| Target Price | $4.50 |
| Price | $0.85 |
| Potential |
429.10%
register free of charge
|
| Number of Estimates | 2 |
|
2 Analysts have issued a price target Hookipa Pharma, Inc. 2026 .
The average Hookipa Pharma, Inc. target price is $4.50.
This is
429.10%
register free of charge
$7.00
723.05%
register free of charge
$2.00
135.16%
register free of charge
|
|
| A rating was issued by 3 analysts: 1 Analysts recommend Hookipa Pharma, Inc. to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Hookipa Pharma, Inc. stock has an average upside potential 2026 of
429.10%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
Create a premium account to unlock analyst estimates.
Learn more
Powered by
Quarter
Annually
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 43.95 | 6.75 |
| 118.33% | 84.64% |
2 Analysts have issued a sales forecast Hookipa Pharma, Inc. 2025 . The average Hookipa Pharma, Inc. sales estimate is
$6.8m
Unlock
84.64%
lower
Unlock
$13.5m
69.28%
Unlock
$0.0
100.00%
Unlock
This results in the following potential growth metrics:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
Create a premium account to unlock analyst estimates.
Learn more
Powered by
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| EV/Sales | negative |
Current Hookipa Pharma, Inc. Upgrades & Downgrades
Create a Premium account to unlock Upgrades/Downgrades.
Learn more
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jan 10 2025 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Dec 20 2024 |
| JMP Securities |
Locked
➜
Locked
|
Locked | Nov 21 2024 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Nov 15 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jan 10 2025 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Dec 20 2024 |
|
Locked
JMP Securities:
Locked
➜
Locked
|
Nov 21 2024 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Nov 15 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
